270 related articles for article (PubMed ID: 15115262)
1. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
[No Abstract] [Full Text] [Related]
2. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
Nordøy A
Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
[No Abstract] [Full Text] [Related]
4. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
5. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids significantly reduce postprandial triglyceridemia in male smokers: a pilot study.
Rein P; Saely CH; Aczel S; Patsch B; Drexel H
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):e3-4. PubMed ID: 19073364
[No Abstract] [Full Text] [Related]
7. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
8. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
O'Keefe JH; Abuissa H; Sastre A; Steinhaus DM; Harris WS
Am J Cardiol; 2006 Apr; 97(8):1127-30. PubMed ID: 16616012
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
Harper CR; Jacobson TA
Am J Cardiol; 2005 Dec; 96(11):1521-9. PubMed ID: 16310434
[TBL] [Abstract][Full Text] [Related]
10. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
Bays H
Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519
[TBL] [Abstract][Full Text] [Related]
11. [Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester].
MMW Fortschr Med; 2005 Oct; 147(43):61. PubMed ID: 16302427
[No Abstract] [Full Text] [Related]
12. Role of n-3 fatty acids in prevention of disease complications in patients with HIV.
Woods MN
Nutr Clin Care; 2005; 8(1):24-30. PubMed ID: 15850231
[TBL] [Abstract][Full Text] [Related]
13. [N-3 polyunsaturated fatty acid in cardiovascular disease].
Cybulska I
Przegl Lek; 2006; 63(8):685-7. PubMed ID: 17441383
[TBL] [Abstract][Full Text] [Related]
14. [Omega-3 fatty acids in cardiology. Latest developments].
von Schacky C
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
[TBL] [Abstract][Full Text] [Related]
15. n-3 fatty acids and human lipoprotein metabolism: an update.
Harris WS
Lipids; 1999; 34 Suppl():S257-8. PubMed ID: 10419172
[No Abstract] [Full Text] [Related]
16. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
17. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids may prevent sudden cardiac death.
Health News; 2006 Jul; 12(7):2. PubMed ID: 16858748
[No Abstract] [Full Text] [Related]
19. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
20. [EPA and DHA ethyl esters: potential mechanisms of antischemic action].
Cerbone AM; Piemontino U; Coppola A; Albisinni R; Cimino E; Di Minno G
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):743-4. PubMed ID: 12497815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
